W.H.P.M., INC.

W.H.P.M., Inc. is a US-based medical diagnostic company specializing in in vitro diagnostic tests and automated reader systems. The company manufactures and distributes a comprehensive portfolio of clinical diagnostic products including drugs of abuse screening tests, fecal occult blood (iFOB) tests, automated FIT (fecal immunochemical) analyzers, fertility diagnostic tests, and harm reduction testing solutions. The flagship Hemosure® Accu-Reader A100 FIT Analyzer provides automated fecal immunochemical testing for colorectal cancer screening. The company also offers the Hemosure Accu-Reader A100 H. pylori fecal antigen test. W.H.P.M. operates with state-of-the-art manufacturing capabilities and emphasizes research, development, and design to deliver competitive diagnostic solutions. The company maintains an active presence in global medical markets, including participation in MEDICA, the world's leading medical trade fair. Beyond direct product sales, W.H.P.M. offers private label and contract manufacturing services for distribution partners, enabling customized diagnostic solutions. The company serves clinical laboratories, diagnostic centers, and healthcare facilities requiring reliable screening and detection capabilities. Products are designed to meet clinical standards for specimen validity and diagnostic accuracy.